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Purpose: To determine the impact of an AngioVue software upgrade on total retinal
thickness (RT) and inner retinal vessel density (VD) measurements derived from optical
coherence tomography angiography (OCTA).
Methods:OptovueOCTA images (3× 3mm) from126 individuals (105 healthy eyes and
72 eyeswith retinal disease)were acquired before an upgrade of theAngioVue software,
which resulted in an inward shift of the outer boundary of the inner retinal vessels and
improved Bruch’s membrane segmentation. Total RT and inner retinal VD values were
extractedbefore andafter the softwareupgrade for comparison. Bias and limits of agree-
ment (LA) were calculated.
Results: The mean (SD) age of participants was 46 (17) years. Mean (LA) foveal RT
increased by 3.0 (–11 to +17) and 3.7 (–11 to +18) µm (P < 0.001) and parafoveal RT
increased by 9.7 (–3.8 to +23) and 6.4 (–2.5 to +15) µm (P < 0.001) in healthy and
diseased retina, respectively. Mean (LA) foveal inner retinal VD decreased by 6.6 (2.5–11)
and 7.7 (0.4–15) percentage units (P< 0.001) and parafoveal inner retinal VD decreased
by 4.1 (1.2–7.0) and 4.7 (0.5–8.9) percentage units (P < 0.001) in healthy and diseased
retina, respectively.
Conclusions: The AngioVue software upgrade resulted in an unexpected increase in
total RT and an expected reduction in inner retinal VD measurements in all regions due
to altered segmentation.
Translational Relevance: RT and VD measures derived from the newer AngioVue
software version are not directly comparable to the reported normative data derived
from the older software.
Introduction
Retinal diseases often affect thickness of the retina;
therefore, mapping and measurement of the retinal
layer thickness is important in diagnosis and disease
management.1–4 Similarly, quantitative characteriza-
tion of the retinal vessel density plays an important
role in detecting and monitoring the development of
subclinical retinal vascular diseases, including diabetic
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retinopathy and branch retinal vain occlusion.5–8 The
easy accessibility to optical coherence tomography
(OCT) and OCT angiography (OCTA) systems has
transformed clinical practice; however, quantitative
analysis is only meaningful if the onboard software can
delineate boundaries within the retina accurately and
reliably.
The AngioVueTM Imaging System (RTVue XR
Avanti, Optovue Inc., Fremont, CA, USA) is a
spectral-domain optical coherence tomography
(SD-OCT) device that enables simultaneous three-
dimensional (3D) structural imaging of the retina and
generation of en face maps of blood flow through a
split-spectrum amplitude decorrelation angiography
algorithm.9 The AngioVue software allows retinal
thickness (RT) and vessel density (VD) to be calcu-
lated from selected regions of the retina. Several
reports have been published on normative values
delivered by the instruments, and many studies have
examined the intra- and inter-session repeatability
of retinal layer thickness and superficial capillary
density measurements from the RTVue XR Avanti
SD-OCT.2,7,8,10–16 Based on recent clinicohistological
correlations, Campbell et al.17 redefined the bound-
aries among four retinal capillary plexuses. These new
boundaries were adopted by the AngioVue software
upgrade from Phase 6.5 to Phase 7.0 and applied
to VD measurements of the inner retinal vascula-
ture. In the previous software version, the superficial
retinal vessel (SRV) slab incorporated flow signals
from three separate anatomic layers, including nerve
fiber, ganglion cell, and inner plexiform layers. The
outer limit of this inner retinal vasculature was shifted
inward (toward the inner limiting membrane), from
the inner nuclear layer to the inner plexiform layer,
and was renamed the superficial vascular complex
(SVC) slab, as it includes two vascular plexuses: radial
peripapillary capillary plexus and superficial vascular
plexus. Consequently, the outer retinal vasculature
slab increased in thickness and was renamed the deep
vascular complex, comprised of the intermediate
capillary plexus and deep capillary plexus. Likewise,
segmentation lines for various sublayer RT measure-
ments have been updated (from four to eight), and
these changes have had an impact on the appearance
of the OCTA and OCT en face slabs. Segmentation of
the inner limiting membrane and Bruch’s membrane
boundaries was unaltered. Another improvement in
the AngioVue Phase 7.0 software upgrade is the provi-
sion for manual segmentation and a propagation tool
to allow efficient correction of segmentation error and
enhancement of en face image accuracy.
There is no doubt that this software upgrade may
enhance diagnostic sensitivity, as the new segmen-
tation boundaries closely mirror the vascular layers
seen in histological sections.17,18 However, the impact
of this segmentation algorithm change on total RT
and inner retinal VDmeasurements remains unknown.
Furthermore, the new software recalculates the exist-
ing datasets collected before the upgrade but does not
save the previous RT and VD calculations derived
from the older software version. Therefore, it is impor-
tant to know the magnitude of the change in RT and
VD from altered segmentation so that measurements
derived from data collected after software upgrade can
be compared to the normative ranges for total RT and
inner retinal VD established with the older software.
To estimate the change in RT and VD arising from
the altered segmentation algorithm in the RTVue XR
Avanti SD-OCT device, we compared these measure-
ments obtained from the same OCT volume data,
before and after the software upgrade, and calculated
the mean differences and their limits of agreement in
clinically healthy and diseased retinas.
Methods
Subjects
This was a retrospective cross-sectional study of
retinal OCTA images stored in the image database
at a single retina practice. The study protocol
(RA/4/20/4275) was reviewed by the Office of Research
Enterprise and the institutional review board (IRB) of
the University of Western Australia, and it was consid-
ered exempt from full ethics review by the board as
this was a retrospective review of anonymized imaging
and clinical data collected as part of routine clinical
care. All patients and their legal guardian (if a minor)
gave consent at the time of ophthalmic assessment for
their anonymized imaging and clinical data to be used
for audit and research. OCTA images from a separate
cohort of healthy subjects recruited prospectively to
establish a normative database under another study
protocol (RA/4/1/8570) approved by the same IRB
were also used in this study. These subjects also gave
consent for retinal imaging and use of their OCTA
image for this research. The research was conducted
in accordance with the tenets of the Declaration of
Helsinki.
Prior to the software upgrade, we kept an image
database of patients who underwent Optovue OCTA
imaging and subjects who were recruited for establish-
ing a normative database. All subjects in this database
were eligible for inclusion, as their old RT and VD
measurements were exported prior to upgrade. If RT
and VD measurements from two or more OCTA
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images were available for one eye, the result from the
first OCTA image was chosen for analysis. This study
would not have been possible if we did not keep an old
record of the previous measurements, as the upgrade
was irreversible; all existing OCTA images were re-
segmented automatically with the upgrade, and previ-
ous RT and VD measurements were overwritten by
the new measurements. The medical charts of these
eligible patients were reviewed to confirm that they
did not have clinically significant lenticular opacities,
corneal opacities, or a history of refractive surgery or
intraocular inflammation. Diabetic retinopathy grades
of R1, R2, and R3S (stable) were assigned as defined
by the National Health Service diabetic eye screen-
ing program.19 Healthy cohorts were recruited prospec-
tively from volunteers and patients attending the eye
clinic with no history of ocular disease and normal
retinal examination and imaging. All healthy subjects
within the database were recruited for a previous
prospective study, and they had a best-corrected Early
Treatment Diabetic Retinopathy Study (ETDRS) letter
score of 85 or greater. Those with any macular pathol-
ogy on structural OCT scan were excluded from the
prospective healthy control cohort. All retinal patients
and healthy subjects underwent retinal OCTA imaging
after pupils were dilated using 1% tropicamide with or
without 2.5% phenylephrine eye drops.
Optical Coherence Tomography
Angiography Imaging Protocol
OCTA images, 3 × 3 mm, used in this study
were acquired using the RTVue XR Avanti system,
Version 2016.1.0.26 (Optovue). Each scan set contains
a horizontal-priority (fast-x) and a vertical-priority
(fast-y) raster OCT volume, and these are combined
automatically by the AngioVue software via 3D
orthogonal registration (motion correction technology,
or MCT), thereby removing bulk motion and gener-
ating a merged OCTA image for all dimensions with
reduced motion artifacts.
Optical Coherence Tomography
Angiography Segmentation
Four segmentation lines are provided by the Phase
6.5 software: inner limiting membrane (ILM), inner
plexiform layer (IPL), outer plexiform layer (OPL), and
Bruch’s membrane; however, the Phase 7.0 software
segments the retina into eight layers. The boundaries
used to define these layers include the ILM, outer limit
of the nerve fiber layer (NFL), outer limit of the IPL,
outer limit of the inner nuclear layer (INL), outer
limit of the OPL, inner/outer segment (IS/OS), apical
boundary of retinal pigment epithelium (RPE), and
Bruch’s membrane. Definitions of the specific retinal
layers are summarized in Supplementary Table S1.
Optical Coherence Tomography
Angiography: Acquisition, Post-Processing,
and Image-Analysis Tools
In both Phase 6.5 and Phase 7.0 versions of the
AngioVue software, DualTracTM Motion Correction
is used to correct for motion artifacts. DualTrac is a
two-level approach to correcting motion artifacts. The
first level provides real-time correction for rapid eye
movements, blinking, or eye drifting by using a real-
time eye tracking function. The second level occurs
during postprocessing of imaging and corrects smaller
levels of motion distortion.MCT registers two volumes
that are acquired with orthogonal scanning axes,
and their postprocessing further improves the motion
correction accuracy and resulting image quality.
AngioAnalytics is the onboard software for the
AngioVue OCTA device that offers a number of tools
to quantify various retinal vasculature parameters.
These parameters, available for Phase 6.5 and Phase 7.0
versions of the software, are summarized in Supple-
mentary Table S2. See Supplementary Table S3 for a
more detailed explanation of the terminology used in
the older and newer software upgrades. RT and inner
retinal VD measurements in the whole image and the
various regions of interests were extracted from the
device before and after the software upgrade. Superfi-
cial retinal vessel density (SRVD) refers to the density
parameter extracted prior to the upgrade, and super-
ficial vascular complex density (SVCD) refers to the
density parameter extracted after the software upgrade.
Statistical Analyses
Each eye was treated independently because the
same image from the same retina was segmented twice
and the comparison was made in RT and VD derived
from these two segmentation algorithms. Statistical
analyses were performed separately for eyes with clini-
cal retinal lesions (diseased retina) and eyes without
clinical retinal disease (normal retina). Some patients
had unilateral retinal conditions; hence, the diseased
eye was allocated to the diseased retina group, and the
unaffected eye was allocated to normal retinal group.
Using Bland-Altman plots and limits of agreement,
we evaluated agreement between RT values derived
from the Phase 6.5 and Phase 7.0 software (ILM–
RPE distance [µm]) and SRVD (Phase 6.5) versus
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SVCD (Phase 7.0) as the number of bright pixels/total
number of pixels in each image (% pixels).20 These
analyses were performed for the 18 regions (whole,
fovea, parafovea, six parafoveal subregions, and the
nine square zones for the vascular density measures)
in the central 3 × 3 mm retina (see Supplementary
Fig. S1).
To determine whether bias increased with magni-
tude, absolute difference was plotted against their
means. The bias (mean difference), standard deviation
of the differences, and 95% confidence limits for the
bias (i.e., the limits of agreement, defined as mean
difference ± 1.96 SD of the differences) were calcu-
lated. The bias and LA are displayed in Figure as solid
and dashed lines, respectively. The LA represents the
range of values for the differences between themethods
that can be expected 95% of the time. The 95% confi-
dence intervals for the mean and the upper and lower
LA were also calculated and tabulated. Paired t-tests
were used to examine the significance of the bias. The
t-statistic (tstat) is given by
tstat = d¯
SE
(
d¯
) (1)
where d¯ is the mean difference, and SE (d¯ ) = sd/√n is
the standard error of the mean difference calculated
under the null hypothesis. P ≤ 0.05 was considered
statistically significant.
Relative change as a percentage of initial measure-
ment was also calculated to estimate the impact of the
software upgrade:
Relative change = 100× (y − x)
x
(2)
where x and y are the measured retinal thickness and
vessel density values before and after the software
upgrade, respectively.
Results
Patient Characteristics
Our image database contained 84 OCTA reports
on RT and VD from 45 healthy subjects (6 eyes had
missing data) and 93 OCTA reports on RT and VD
from 50 retinal patients (7 eyes had missing data).
A total of 177 OCTA images, including 84 eyes of
healthy subjects, 21 eyes with clinically normal retina
in patients, and 72 eyes of clinically diseased retina
in patients, were included in the analyses (Table 1).
Among the 72 eyes with retinal disease, 43 eyes of 24
patients had diabetic retinopathy, 14 eyes of 14 patients
had retinal vein occlusion, 7 eyes of 7 patients had
adult Coats disease, 4 eyes of 2 patients had retinitis
pigmentosa, 2 eyes of a patient had macular dystro-
phy, 1 eye of a patient had macular telangiectasia, and
1 eye of a patient had radiation retinopathy. The 21
eyes with clinically normal retina came from 13 patients
with unilateral retinal vein occlusion, the 7 patients
with unilateral adult Coats disease, and the patient with
unilateral radiation retinopathy. The mean age (SD,
range) of all participants was 46 (17, 10–84) years. The
mean (SD, range) visual acuity in ETDRS letter score
was 75.1 (11.4, 38–94) letters in the cohort with retinal
disease.
Increased Retinal Thickness Measurement
The mean (SD) increase in foveal region RT were
3.00 (7.00) µm in healthy retinas and 3.65 (7.33) µm
in diseased retinas (P < 0.001 and P < 0.001, respec-
tively). The lower and upper bounds of the LA for
both groups were –10.72 and +16.72 µm and –10.71
and +18.02 µm, respectively. The mean (SD) increase
in parafoveal region RT were 9.74 (6.89) µm in healthy
retinas and 6.40 (4.56) µm in diseased retinas, which
were also statistically significant for both healthy (P <
0.05) and diseased (P < 0.001) retinas. The lower and
upper bounds of the LA were –3.76 and +23.25 µm
and –2.54 and +15.35 µm for healthy and diseased
retinas, respectively (Table 2, Fig. 1). There were no
obvious relationships between the changes in RT from
the software upgrade and image quality based on the
new scan quality index (Supplementary Fig. S2).
Relative change (as a percentage of the original
values from the old software) in foveal RT ranged
from –15.41% to +8.00% for healthy retinas and from
–9.25% to +8.31% for diseased retinas (Fig. 2). In
the parafoveal region, the relative change varied from
–6.98% to +9.17% for healthy retinas and –1.79% to
+6.06% for diseased retinas (Fig. 2). Supplementary
Table S5 summarizes the measured values for total
RT before and after the software upgrade stratified by
disease status for each zone.
Reduced Vessel Density Measurement
Foveal SRCD (new software) was lower than foveal
SRVD (old software) by mean (SD) differences of –
6.60 (2.12) and –7.65 (3.68) % in healthy and diseased
retinas, respectively (P < 0.001) (Table 3, Fig. 1). The
lower and upper bounds of the LA for each group
were –10.74 to –2.45% for healthy retinas and –14.85
to –0.44% for diseased retinas. Similarly, parafoveal
SVCD was lower than parafoveal SRVD by mean (SD)
differences of –4.11 (1.47) % for healthy retinas and
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Figure 1. A series of Bland–Altman plots illustrate the agreement in total RT and inner retinal VD before and after the software upgrade.
The newer software measures a significantly greater foveal (A) and parafoveal (B) RT in healthy retina. This pattern is also observed in foveal
(C) and parafoveal (D) RT in diseased retina. Foveal (E) and parafoveal (F) inner retinal VD are consistently lowerwhen derived from the newer
software in healthy retina. The difference remains significant in foveal and parafoveal inner retinal VD in diseased retina (G, H). The solid line
is the mean difference (value after upgrade – value before upgrade), and the dotted lines denote 1.96 × standard deviations above and
below the mean difference.
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Figure 2. A series of histograms show the frequency of relative percentage change in foveal and parafoveal RT in healthy retina (A, B) and
diseased retina (C, D) subjects. Foveal and parafoveal VD in healthy retina (E, F) and diseased retina (G, H) are both significantly lower in
the newer software. Relative change is defined by the difference between the values (after – before) divided by the value obtained prior to
upgrade.
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Table 1. Demographics of Study Subjects
Demographic
Bilateral or Unilateral
Healthy Retina
Bilateral or Unilateral
Diseased Retina
Number of patients (n) 66 50
Age (y), mean (SD) 41.4 (16.6) 56.5 (15.1)
Gender M:F (n) 33:33 30:20
Age distribution (n)
<30 23 1
31–40 15 8
41–50 7 7
51–60 10 11
61–70 9 16
>70 2 7
Eyes included in the study (n) 105 72
Visual acuity in ETDRS letters, mean (SD) >85a 75.1 (11.4)
Diagnosis (n)
Diabetic retinopathy NA 43
Retinal vein occlusion NA 14
Coats disease NA 7
Othersb NA 8
Scan quality (n)
1–4 4 8
5 7 3
6 6 11
7 26 24
8 43 20
9 19 6
NA; not applicable.
aTesting of visual acuity in this cohort did not continue beyond 85 letters.
bIncludes retinitis pigmentosa, macular dystrophy, macular telangiectasia, and radiation retinopathy.
–4.68 (2.15) % for diseased retinas (P < 0.001), with
lower and upper bounds of the LA of –7.0 to –1.22%
for healthy retinas and –8.90 to –0.46% for diseased
retinas (Table 3, Fig. 1). A similar mean difference
between SRVDand SVCDwas observed for each of the
nine 1× 1-mm zones (Supplementary Table S4). There
were no obvious relationships between the changes in
VD from the software upgrade and image quality based
on the new scan quality index (Supplementary Fig. S2).
The relative change (as a percentage of the measure-
ments from the old software) in foveal inner retinal VD
ranged from –4.57% to –44.42% in healthy retinas and
from –73.85% to+4.86% in diseased retinas. Similarly,
the relative change in parafoveal inner retinal VD
ranged from–12.83% to+0.45% for healthy retinas and
–1.99% to –27.53% for diseased retinas. Figure 3 illus-
trates the position of the segmentation line marking
the outer boundary of the SRV (within INL) and
SVC (within IPL) and the density maps generated
before and after the upgrade to Phase 7.0 software
for two healthy subjects, and Figure 4 shows the
same for two selected patients with retinal diseases
(see Supplementary Fig. S3 for higher magnification
of Figs. 3 and 4). Supplementary Table S6 summarizes
the measured values for inner retinal VD before and
after the software upgrade stratified by disease status
for each zone.
Discussion
The altered segmentation boundary from the
software upgrade has had a significant impact
on total retinal thickness and inner retinal vessel
density measurements. There was an overall significant
increase in foveal and parafoveal RT measurements
derived from the new software. Furthermore, SVCD
generated from the new software was lower than SRVD
derived from the older software, and the discrepancy
Downloaded from tvst.arvojournals.org on 02/16/2020
Impact of Software Upgrade on OCTA Parameters TVST | February 2020 | Vol. 9 | No. 3 | Article 10 | 8
Ta
bl
e
2.
Bl
an
d–
Al
tm
an
An
al
ys
is
an
d
Pa
ire
d
t-T
es
ts
Sh
ow
in
g
th
e
Ag
re
em
en
ti
n
O
CT
Re
tin
al
Th
ic
kn
es
sD
er
iv
ed
fro
m
Ph
as
e
6.
5
an
d
Ph
as
e
7.
0
Li
m
its
of
Ag
re
em
en
t
Re
tin
al
Th
ic
kn
es
s(
µm
)
M
ea
n
D
iff
er
en
ce
(9
5%
CI
)
SD
Lo
w
er
(9
5%
CI
)
U
pp
er
(9
5%
CI
)
t st
at
P
H
ea
lth
y
su
bj
ec
ts
(n
=
10
5)
Fo
ve
al
ci
rc
le
+3
.0
0
(+
1.
64
,+
4.
36
)
7.
00
–1
0.
72
(–
13
.0
6,
–8
.3
7)
+1
6.
72
(+
14
.3
7,
+1
9.
06
)
+4
.3
9
<
0.
00
1
Pa
ra
fo
ve
al
rim
+9
.7
4
(+
8.
41
,+
11
.0
8)
6.
89
–3
.7
6
(–
6.
07
,–
1.
45
)
+2
3.
25
(+
20
.9
4,
+2
5.
56
)
+1
4.
49
<
0.
00
1
Su
pe
rio
r-h
em
i
+1
0.
04
(+
8.
62
,+
11
.4
5)
7.
31
–4
.2
8
(–
6.
74
,–
1.
83
)
+2
4.
36
(+
21
.9
1,
+2
6.
81
)
+1
4.
08
<
0.
00
1
In
fe
rio
r-h
em
i
+9
.5
0
(+
8.
18
,+
10
.8
1)
6.
81
–3
.8
7
(–
6.
13
,–
1.
56
)
+2
2.
84
(+
20
.5
5,
+2
5.
12
)
+1
4.
29
<
0.
00
1
Te
m
po
+9
.7
1
(+
8.
27
,+
11
.1
6)
7.
45
–4
.8
8
(–
7.
38
,–
2.
38
)
+2
4.
31
(+
21
.8
1,
+2
6.
81
)
+1
3.
37
<
0.
00
1
Su
pe
rio
r
+1
0.
02
(+
8.
56
,+
11
.4
8)
7.
56
–4
.8
0
(–
7.
33
,–
2.
26
)
+2
4.
84
(+
22
.3
0,
+2
7.
37
)
+1
3.
58
<
0.
00
1
N
as
al
+9
.9
0
(+
8.
44
,+
11
.3
7)
7.
56
–4
.9
1
(–
7.
45
,–
2.
38
)
+2
4.
72
(+
22
.1
9,
+2
7.
26
)
+1
3.
42
<
0.
00
1
In
fe
rio
r
+9
.4
6
(+
8.
12
,+
10
.7
9)
6.
90
–4
.0
7
(–
6.
38
,–
1.
75
)
+2
2.
98
(+
20
.6
7,
+2
5.
30
)
+1
4.
04
<
0.
00
1
Re
tin
al
di
se
as
e
(n
=
72
)
Fo
ve
al
ci
rc
le
+3
.6
5
(+
1.
93
,+
5.
37
)
7.
33
–1
0.
71
(–
13
.6
9,
–7
.7
4)
+1
8.
02
(+
15
.0
4,
+2
1.
00
)
+4
.2
3
<
0.
00
1
Pa
ra
fo
ve
al
rim
+6
.4
0
(+
5.
33
,+
7.
47
)
4.
56
–2
.5
4
(–
4.
40
,–
0.
69
)
+1
5.
35
(+
13
.5
0,
+1
7.
20
)
+1
1.
90
<
0.
00
1
Su
pe
rio
r-h
em
i
+6
.6
9
(+
5.
40
,+
7.
99
)
5.
52
–4
.1
3
(–
6.
37
,–
1.
89
)
+1
7.
52
(+
15
.2
8,
+1
9.
76
)
+1
0.
29
<
0.
00
1
In
fe
rio
r-h
em
i
+6
.1
9
(+
4.
94
,+
7.
45
)
5.
34
–4
.2
8
(–
6.
45
,–
2.
11
)
+1
6.
67
(+
14
.5
0,
+1
8.
84
)
+9
.8
4
<
0.
00
1
Te
m
po
+6
.6
4
(+
5.
27
,+
8.
01
)
5.
85
–4
.8
2
(–
7.
20
,–
2.
45
)
+1
8.
10
(+
15
.7
3,
+2
0.
48
)
+9
.6
3
<
0.
00
1
Su
pe
rio
r
+6
.4
3
(+
4.
93
,+
7.
93
)
6.
38
–6
.0
8
(–
8.
67
,–
3.
49
)
+1
8.
94
(+
16
.3
5,
+2
1.
53
)
+8
.5
5
<
0.
00
1
N
as
al
+6
.5
7
(+
5.
06
,+
8.
08
)
6.
43
–6
.0
4
(–
8.
66
,–
3.
43
)
+1
9.
18
(+
16
.5
7,
+2
1.
79
)
+8
.6
6
<
0.
00
1
In
fe
rio
r
+5
.9
6
(+
4.
58
,+
7.
34
)
5.
89
–5
.5
8
(–
7.
97
,–
3.
19
)
+1
7.
50
(+
15
.1
1,
+1
9.
89
)
+8
.5
9
<
0.
00
1
Downloaded from tvst.arvojournals.org on 02/16/2020
Impact of Software Upgrade on OCTA Parameters TVST | February 2020 | Vol. 9 | No. 3 | Article 10 | 9
Ta
bl
e
3.
Bl
an
d–
Al
tm
an
An
al
ys
is
an
d
Pa
ire
d
t-T
es
ts
Sh
ow
in
g
th
e
Ag
re
em
en
tB
et
w
ee
n
SR
VD
(P
ha
se
6.
5)
an
d
SV
CD
(P
ha
se
7.
0)
Li
m
its
of
Ag
re
em
en
t
SV
CD
–
SR
VD
(%
pi
xe
ls)
M
ea
n
D
iff
er
en
ce
(9
5%
CI
)
SD
Lo
w
er
(9
5%
CI
)
U
pp
er
(9
5%
CI
)
t st
at
P
H
ea
lth
y
su
bj
ec
ts
(n
=
10
5)
W
ho
le
re
tin
a
–4
.3
4
(–
4.
62
,–
4.
06
)
1.
45
–7
.1
9
(–
7.
68
,–
6.
70
)
–1
.5
0
(–
1.
98
,–
1.
01
)
–3
0.
64
<
0.
00
1
Fo
ve
al
ci
rc
le
–6
.6
0
(–
7.
01
,–
6.
19
)
2.
12
–1
0.
74
(–
11
.4
5,
–1
0.
03
)
–2
.4
5
(–
3.
16
,–
1.
74
)
–3
1.
95
<
0.
00
1
Pa
ra
fo
ve
al
rim
–4
.1
1
(–
4.
39
,–
3.
82
)
1.
47
–7
.0
0
(–
7.
49
,–
6.
50
)
–1
.2
2
(–
1.
71
,–
0.
73
)
–2
8.
57
<
0.
00
1
Su
pe
rio
r-h
em
i
–4
.0
5
(–
4.
36
,–
3.
75
)
1.
57
–7
.1
4
(–
7.
66
,–
6.
61
)
–0
.9
7
(–
1.
50
,–
0.
44
)
–2
6.
40
<
0.
00
1
In
fe
rio
r-h
em
i
–4
.1
7
(–
4.
47
,–
3.
87
)
1.
54
–7
.1
9
(–
7.
71
,–
6.
67
)
–1
.1
5
(–
1.
67
,–
0.
64
)
–2
7.
76
<
0.
00
1
Te
m
po
–4
.3
6
(–
4.
69
,–
4.
02
)
1.
74
–7
.7
7
(–
8.
35
,–
7.
18
)
–0
.9
5
(–
1.
53
,–
0.
36
)
–2
5.
67
<
0.
00
1
Su
pe
rio
r
–3
.8
9
(–
4.
20
,–
3.
59
)
1.
58
–7
.0
0
(–
7.
53
,–
6.
47
)
–0
.7
9
(–
1.
32
,–
0.
26
)
–2
5.
20
<
0.
00
1
N
as
al
–4
.2
9
(–
4.
62
,–
3.
97
)
1.
68
–7
.5
9
(–
8.
15
,–
7.
03
)
–0
.9
9
(–
1.
56
,–
0.
43
)
–2
6.
14
<
0.
00
1
In
fe
rio
r
–4
.0
2
(–
4.
33
,–
3.
70
)
1.
64
–7
.2
3
(–
7.
78
,–
6.
68
)
–0
.8
0
(–
1.
35
,–
0.
25
)
–2
5.
07
<
0.
00
1
Re
tin
al
di
se
as
e
(n
=
72
)
W
ho
le
re
tin
a
–4
.9
9
(–
5.
49
,–
4.
49
)
2.
15
–9
.2
0
(–
10
.0
8,
–8
.3
3)
–0
.7
8
(–
1.
65
,+
0.
09
)
–1
9.
70
<
0.
00
1
Fo
ve
al
ci
rc
le
–7
.6
5
(–
8.
51
,–
6.
78
)
3.
68
–1
4.
85
(–
16
.3
5,
–1
3.
36
)
–0
.4
4
(–
1.
93
,+
1.
06
)
–1
7.
64
<
0.
00
1
Pa
ra
fo
ve
al
rim
–4
.6
8
(–
5.
19
,–
4.
18
)
2.
15
–8
.9
0
(–
9.
78
,–
8.
03
)
–0
.4
6
(–
1.
34
,+
0.
41
)
–1
8.
45
<
0.
00
1
Su
pe
rio
r-h
em
i
–4
.8
7
(–
5.
44
,–
4.
30
)
2.
43
–9
.6
3
(–
10
.6
2,
–8
.6
4)
–0
.1
0
(–
1.
09
,+
0.
89
)
–1
6.
99
<
0.
00
1
In
fe
rio
r-h
em
i
–4
.5
1
(–
5.
11
,–
3.
91
)
2.
55
–9
.5
1
(–
10
.5
4,
–8
.4
7)
+0
.4
8
(–
0.
55
,+
1.
52
)
–1
5.
03
<
0.
00
1
Te
m
po
–4
.9
6
(–
5.
60
,–
4.
33
)
2.
71
–1
0.
27
(–
11
.3
7,
–9
.1
7)
+0
.3
5
(–
0.
75
,+
1.
45
)
–1
5.
55
<
0.
00
1
Su
pe
rio
r
–4
.7
3
(–
5.
43
,–
4.
03
)
2.
97
–1
0.
55
(–
11
.7
6,
–9
.3
5)
+1
.0
9
(–
0.
11
,+
2.
30
)
–1
3.
51
<
0.
00
1
N
as
al
–4
.4
5
(–
4.
97
,–
3.
93
)
2.
22
–8
.8
1
(–
9.
71
,–
7.
91
)
–0
.1
0
(–
1.
00
,+
0.
80
)
–1
7.
00
<
0.
00
1
In
fe
rio
r
–4
.5
9
(–
5.
23
,–
3.
95
)
2.
72
–9
.9
3
(–
11
.0
3,
–8
.8
2)
+0
.7
5
(–
0.
36
,+
1.
85
)
–1
4.
30
<
0.
00
1
Downloaded from tvst.arvojournals.org on 02/16/2020
Impact of Software Upgrade on OCTA Parameters TVST | February 2020 | Vol. 9 | No. 3 | Article 10 | 10
Figure 3. Illustration of the segmentation line (A, B, E, F) and density map (C, D, G, H) generated before and after the upgrade to Phase 7.0
software for healthy retina. In case 1 (A–D), the relative changes in foveal inner retinal VD and RT are –16.02% and+8%, respectively. In case
2 (E, H), the relative changes in foveal VD and RT are –44.42% and+0.92%, respectively.
Figure 4. Illustration of the segmentation line (A, B, E, F) and density map (C, D, G, H) generated before and after the upgrade to Phase 7.0
software for diseased retina. In case 1 (A–D), a patient with diabetic retinopathy, the relative changes in foveal VD and RT are –62.14% and
+0.53%; respectively. In case 2 (E–H), a patient with diabetic retinopathy, the relative changes in foveal VD and RT are+4.2% and –15.80%,
respectively.
appeared to be greater for diseased eyes but not
dependent on image quality. Although the difference
between SRVD (Phase 6.5) and SVCD (Phase 7.0) can
be readily explained by the thinner slab and removal
of flow projection artifacts21 applied in a new version
of the software, it is not clear why variations are also
observed in RT measurement.
The impact of different segmentation algorithm on
RT measurement has been demonstrated previously
when different devices were compared. Bentaleb-
Machkour et al.22 compared central macular thick-
ness measurements obtained using the Stratus OCT
(Carl Zeiss Meditec, Inc., Dublin, CA, USA), Cirrus
HD-OCT (Carl Zeiss Meditec), and 3D-OCT 1000
(Topcon Corporation, Tokyo, Japan). They concluded
in their study that the different OCT devices cannot
be used interchangeably due to differences in the
segmentation algorithms. Lammer et al.23 compared
RT measurements by four spectral OCT devices—
Spectralis HRA+OCT (Heidelberg Engineering,
Heidelberg, Germany), Cirrus HD-OCT, Topcon 3D
OCT-1000, and Stratus OCT—and also reported a
lack of inter-device agreement that seemed to be
related to differences in the segmentation algorithms.
The same observations have been reported by Pierro
et al.,24 who compared the measurement of retinal
NFL thickness by six different devices, including
Optovue OCT devices; by Sull et al.,25 who compared
RT measurements by four OCT instruments (includ-
ing Optovue); and Wolf-Schmurrbusch et al.,26 who
compared central RTmeasurement by six OCT devices
(including Optovue).
Only one report has demonstrated the impact of
software upgrades in retinal segmentation algorithms
on output parameters. In 2015, Hollo et al.27 investi-
gated the impact of a software upgrade for theOptovue
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RTVue-100 OCT (version 6.3 to 6.12) for the detec-
tion of glaucoma using inner macular retinal thick-
ness and retinalNFL thickness progression. The aim of
the study was to evaluate the potential clinical useful-
ness of the new software version for detection of
glaucomatous progression. In this study, 109 partic-
ipants were investigated at 6-month intervals (mean
follow-up 5 years). The authors demonstrated that
measurement variability was significantly lower with
the newer software version for all measured parame-
ters and attributed the improvement to better image
segmentation algorithms. To explain our observation
of the unexpected increase in parafoveal RT in healthy
and diseased eyes, close inspection of the segmenta-
tion lines scan by scan, before and after the software
upgrade, is essential. However, the software upgrade
was irreversible, and it is not possible to revert back
to the older version to examine this difference. There-
fore, caution is required when comparing data derived
from different versions of the software on the same
device. For healthy eyes, previously published RTs need
to be increased by the conversion factors summarized
in Table 2 before they can be compared to RTs derived
from the new software version.
OCTA-derived vessel density measure can also vary
significantly among devices. Munk et al.28 compared
four OCTA devices: Topcon DRI OCT Triton,
Optovue RTVue XR, a prototype Spectralis OCT2,
and Cirrus 5000-HD-OCT. Although they reported
no significant differences in mean vessel densities
among these modules, they observed a weak correla-
tion among the devices, which suggests that artifacts
and differences in slab boundary segmentation may
have a significant impact on the measurement of vessel
density. Lei et al.29 tested the repeatability and repro-
ducibility of measurements of peripapillary capillar-
ies in the same study subjects using the Spectralis
OCT2 OCTA module, RTVue XR Avanti AngioVue,
TopconDRIOCTTriton, and Cirrus HD-5000 Angio-
Plex OCTA instruments. Although the study revealed
that the repeatability of measuring peripapillary capil-
laries was high for all four devices, the reproducibil-
ity among the machines was not. This was attributed
to differences in the segmentation boundaries between
the instruments. The same observation, that differ-
ences in segmentation algorithms and resultant bound-
aries preclude meaningful comparisons among OCTA
devices, was also made by the Corvi et al.,30 who
compared results obtained from seven different OCT
instruments. Given that the outer boundaries or super-
ficial retinal vessels in the older Phase 6.5 software are
shifted from the INL to the IPL to define the outer
boundary of the superficial vascular complex in the
newer Phase 7.0 version, it is not surprising that there
is an overall reduction in density measures. However,
it is important to note that the greater SD of the bias
and LA in diseased retina suggests that segmentation
errors in the altered outer boundary may reduce the
accuracy of a conversion factor. For healthy eyes, previ-
ously published SRVD values may have to be reduced
by the conversion factors as summarized in Table 3
prior to comparison with SVCD values derived from
the new software version.
Although we were able to provide an estimate of
the magnitude of the change in RT and VD from this
software upgrade, there are a number of significant
limitations in this study. First, the sample size was
small, with the majority being affected by retinal vascu-
lar diseases (diabetic retinopathy, retinal vein occlu-
sion, and Coats disease). The differences in thick-
ness and density measures between the two software
versions may be greater if we had access to images
that showed vitreomacular traction disorders or outer
retinal abnormalities. Second, we only examined the
differences in the inner retinal vessels (SRV vs. SVC) in
a 3 × 3-mm scanning protocol. Neither foveal avascu-
lar zone areas nor deep capillary or vascular complex
densities were compared, as we did not have access
to the old foveal avascular zone area calculations and
there was no output for the deep retinal vessel density
from the old software. We also did not export the
6 × 6-mm data prior to the upgrade. Third, we did
not investigate the effect of new segmentation in the
Phase 7.0 version on the test–retest variability thresh-
olds in SVCD, as this would require a prospective
study design. Fourth, although we suspected segmen-
tation error in the ILM and Bruch’s membrane as the
cause of differences in RT between the two software
versions, we were unable to examine every B-scan to
look for segmentation error as this information could
not be exported prior to upgrade. Further analysis is
required to confirm the accuracy of the new segmen-
tation algorithm compared to the previous software.
Finally, we did not take into consideration the effect of
image magnification due to deviation from the default
axial length used by the Optovue device.
Conclusions
We demonstrated the impact of the altered segmen-
tation algorithm and boundaries on RT and VD
measurements. The unexpected change in RTmeasure-
ment should be considered by users of the RTVue
XRAvanti SD-OCT device when comparing outcomes
of analyses before and after the software upgrade.
We recommend that previously published normative
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databases of retinal layer thickness and retinal vascu-
lar density, and their test–retest variability thresholds,
should be recalculated using the new software for
future reference.
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